MD simulations of HIV-1 RT primerlate complex: Effect of modified nucleosides and antisense PNA oligomer

Journal of Biomolecular Structure and Dynamics

Volumn 31, Issue 6, 2013, Pages 539-560

  Uppuladinne, Mallikarjunachari V N ^a   Sonavane, Uddhavesh B ^a   Joshi, Rajendra R ^a  

^a CENTRE FOR DEVELOPMENT OF ADVANCED COMPUTING   (India)

Author keywords

antisense; HIV 1; MD simulations; PNA; primerlate; tRNA 3 Lys modifications

Indexed keywords

PEPTIDE NUCLEIC ACID; RNA DIRECTED DNA POLYMERASE; TRANSFER RNA; VIRUS RNA;

ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME BINDING; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA STABILITY; RNA STRUCTURE;

ANTICODON; BINDING SITES; DNA PRIMERS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; HYDROGEN BONDING; MOLECULAR DYNAMICS SIMULATION; NUCLEIC ACID CONFORMATION; RNA, TRANSFER; RNA, TRANSFER, LYS; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84878686698     PISSN: 07391102     EISSN: 15380254     Source Type: Journal    
DOI: 10.1080/07391102.2012.706076     Document Type: Article

References (60)

1. Abbondanzieri, E.A., Bokinsky, G., Rausch, J.W., Zhang, J.X., Le Grice, S.F.J., and, Zhuang, X. 2008. Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature, 453: 184-189.
2. Agris, P.F. 2004. Decoding the genome: A modified view. Nucleic Acids Research, 32: 223-238.
3. Aiyar, A., Ge, Z., and, Leis, J. 1994. A specific orientation of RNA secondary structures is required for initiation of reverse transcription. Journal of Virology, 68: 611-618.
4. Arts, E.J., Stetor, S.R., Li, X., Rausch, J.W., Howard, K.J., Ehresmann, B., North, T.W.,., and, Le Grice, S.F.J. 1996. Initiation of (-) strand DNA synthesis from tRNA3Lys on lentiviral RNAs: Implications of specific HIV-1 RNA-tRNA3Lys interactions inhibiting primer utilization by retroviral reverse transcriptases. Proceedings of the National Academy of Sciences of the United States of America, 93: 10063-10068.
5. Ashok, C.B., Mallikarjun, S., David, G.M., and, Darrell, R.D. 2002. An RNA complex of the HIV-1 A-loop and tRNALys,3 is stabilized by nucleoside modifications. Journal of American Chemical Society, 124: 14302-14303.
6. Baltimore, D. 1970. Viral RNA-dependent DNA polymerase. Nature, 226: 1209-1211.
7. Benas, P., Bec, G., Keith, G., Maquet, R., and, Ehresmann, C. 2000. The crystal structure of HIV reverse-transcription primer tRNA(Lys,3) shows a canonical anticodon loop. RNA, 6: 1347-1355.
8. Berendsen, H.J.C., Postma, J.P.M., van Gunsteren, W.F., DiNola, A., and, Haak, J.R. 1984. Molecular dynamics with coupling to an external bath. Journal of Computational Physics, 81: 3684-3690.
9. Bilbille, Y., Vendeix, F.A.P., Guenther, R., Malkiewicz, A., Ariza, X., Vilarrasa, J., and, Agris, P.F. 2009. The structure of the human tRNALys3 anticodon bound to the HIV genome is stabilized by modified nucleosides and adjacent mismatch base pairs. Nucleic Acids Research, 37: 3342-3353.
10. Case, D.A., Darden, T.A., Cheatham, T.E. III, Simmerling, C.L., Wang, J., Duke, R.E.,., and, Kollman, P.A. 2008. AMBER 10, San Francisco, CA: University of California.
11. Cheatham, T.E. III, and, Kollman, P.A. 1997. Molecular dynamics simulations highlight the structural differences among DNA:DNA, RNA:RNA and DNA:RNA hybrid duplexes. Journal of American Chemical Society, 119: 4805-4825.
12. Demidov, V.V., Potaman, V.N., Frank-Kamenetskii, M.D., Egholm, M., Buchard, O., Sönnichsen, S.H., and, Nielsen, P.E. 1994. Stability of peptide nucleic acids in human serum and cellular extracts. Biochemical Pharmacology, 48: 1310-1313.
13. Ditchfield, R., Hehre, W.J., and, Pople, J.A. 1971. Self-consistent molecular-orbital methods. IX. An extended Gaussian-type basis for molecular-orbital studies of organic molecules. Journal of Chemical Physics, 54: 724-728.
14. Duan, Y., Wu, C., Chowdhury, S., Lee, M.C., Xiong, G., Zhang, W., and,. 2003. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. Journal of Computational Chemistry, 24 (16): 1999-2012.
15. Egholm, M., Buchardt, O., Sonnichsen, S.H., and, Nielsen, P.E. 1992a. Peptide nucleic acids (PNA). Oligonucleotide analogues with an achiral peptide backbone. Journal of American Chemical Society, 114: 1895-1897.
16. Egholm, M., Buchardt, O., Sonnichsen, S.H., and, Nielsen, P.E. 1992b. Recognition of guanine and adenine in DNA by cytosine and thymine containing peptide nucleic acid. Journal of American Chemical Society, 114: 9677-9678.
17. Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Montgomery, J. A.,. Pople, J. A. (2003). Revision B.04 ed. Pittsburgh, PA: Gaussian, Inc.
18. Harada, F., Perters, G.G., and, Dahlberg, J.E. 1979. The primer tRNA for Moloney murine leukemia virus DNA synthesis. Nucleotide sequence and aminoacylation of tRNAPro. Journal of Biological Chemistry, 254: 10979-10985.
19. Harada, F., Sawyer, R.C., and, Dalhberg, J.E. 1975. A primer ribonucleic acid for initation of in vitro Rous sarcoma virus deoxyribonucleic acid synthesis. Journal of Biological Chemistry, 250: 3487-3497.
20. Hehre, W.J., Ditchfield, R., and, Pople, J.A. 1972. Self-consistent molecular orbital methods. XII. Further extensions of Gaussian-type basis sets for use in molecular orbital studies of organic molecules. Journal of American Chemical Society, 56: 2257-2261.
21. Helence, C. 1997. Specific control of gene expression by oligonucleotides: From chemistry to clinical aspects. Annales Pharmaceutiques Francaises, 55: 95-103.
22. Humphrey, W., Dalke, A., and, Schulten, K. 1996. VMD-visual molecular dynamics. Journal of Molecular Graphics, 14: 33-38.
23. Hyangshuk, R., Jinseu, P., and, Casey, D.M. 1991. Deletions in the tRNALys primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription. Journal of Virology, 65: 4555-4564.
24. Isel, C., Ehresmann, C., and, Marquet, R. 2010. Initiation of HIV reverse transcription. Viruses, 2: 213-243.
25. Isel, C., Ehresmann, C., Keith, G., Ehresmann, B., and, Marquet, R. 1995. Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA3Lys (template/primer) complex. Journal of Molecular Biology, 247: 236-250.
26. Isel, C., Keith, G., Ehresmann, B., Ehresmann, C., and, Marquet, R. 1998. Mutational analysis of the tRNA3Lys/HIV-1 RNA (primer/template) complex. Nucleic Acids Research, 26: 1198-1204.
27. Isel, C., Lanchy, J.M., Le, G.S.F.J., Ehresmann, C., Ehresmann, B., and, Marquet, R. 1996. Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys. The EMBO Journal, 15: 917-924.
28. Isel, C., Marquet, R., Keith, G., Ehresmann, C., and, Ehresmann, B. 1993. Modified nucleotides of transfer-tRNA3Lys modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. Journal of Biological Chemistry, 268: 25269-25272.
29. Isel, C., Westhof, E., Massire, C., Le, S.F.J.G., Ehresmann, B., Ehresmann, C., and, Marquet, R. 1999. Structural basis for the specificity of the initiation of HIV-1 reverse transcription. The EMBO Journal, 18: 1038-1048.
30. Iwatani, Y., Rosen, A.E., Gua, J., Musier-Foryth, K., and, Levin, J.G. 2003. Efficient Initiation of HIV-1 Reverse Transcription in Vitro. Journal of Biological Chemistry, 278: 14185-14195.
31. Jorgensen, W.L., Chandrasekhar, J., and, Madura, J.D. 1983. Comparison of simple potential functions for simulating liquid water. Journal of Chemical Physics, 79: 926-935.
32. Kang, S.M., Wakefield, J.K., and, Morrow, C.D. 1996. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription. Virology, 222: 401-414.
33. Kang, S.M., Zhang, Z.J., and, Morrow, C.D. 1997. Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNAMet. Journal of Virology, 71: 207-217.
34. Kaushik, N., and, Pandey, V.N. 2002. PNA targeting the PBS and A-loop sequences of HIV-1 genome destabilizes packaged tRNA3Lys in the virions and inhibits HIV-1 replication. Virol, 303: 297-308.
35. Kaushik, N., Talele, T.T., Monel, R., Palumbo, P., and, Pandey, V.N. 2001. Destabilization of tRNA3Lys from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog. Nucleic Acids Research, 29: 5099-5106.
36. Kilkuskie, R.E., and, Field, A.K. 1997. Antisense inhibition of virus infections. Advances in Pharmacology, 40: 437-483.
37. Kim, S.K., Nielsen, P.E., Egholm, M., Buchardt, O., Berg, R.H., and, Norden, B. 1993. Journal of American Chemical Society, 115: 6477-6481.
38. Lee, R., kaushik, N., Modak, M.J., Vinayak, R., and, Pandey, V.N. 1998. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription. Biochemistry, 37: 900-910.
39. Leeds, J.M., Hnry, S.P., Truong, L., Zutshi, A., Levin, A.A., and, Kornbrust, D. 1997. Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbit. Drug Metabolism and Disposition, 25: 921-926.
40. Levin, J.G., Guo, J., Rouzina, I., and, Musier-Forsyth, K. 2005. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: Critical role in reverse transcription and molecular mechanism. Progress in Nucleic Acid Research and Molecular Biology, 80: 217-286.
41. Li, Y., Kang, S.M., and, Morrow, C.D. 1997. Stability of HIV type 1 proviral genomes that contain two distinct primer-binding sites. AIDS Research and Human Retroviruses, 13: 253-262.
42. Liang, C., Li, X., Rong, L., Inouye, P., Quan, Y., Kleiman, L., and, Wainberg, M.A. 1997. The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity. Journal of Virology, 71: 5750-5757.
43. Liu, S., Abbondanzieri, E., Rausch, J., Le Grice, S., and, Zhuang, X. 2008. Slide into action: Dynamic shutting of HIV reverse transcriptase on nucleic acid substrates. Science, 322: 1092-1097.
44. Liu, S., Harada, B.T., Miller, J.T., Le Grice, S.F.J., and, Zhuang, X. 2010. Initiation complex dynamics direct the transitions between distinct phases of early HIV reverse transcription. Nature Structural & Molecular Biology, 17: 1453-1460.
45. Mak, J., and, Kleiman, L. 1997. Primer tRNAs for reverse transcription. Journal of Virology, 71: 8087-8095.
46. Marquet, R., Isel, C., Ehresmann, C., and, Ehresmann, B. 1995. TRNAs as primer of reverse transcriptase. Biochimie, 77: 113-124.
47. Muesing, M.A., Smith, D.H., and, Capon, D.J. 1987. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell, 48: 691-701.
48. Nielsen, P.E., Egholm, M., Berg, R.H., and, Buchardt, O. 1991. Sequece-selective recognition of DNA by strand displacement with a thymin-substituted polyamide. Science, 254: 1497-1500.
49. Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and, Ferrin, T.E. 2004. Journal of Computational Chemistry, 25 (13): 1605-1612.
50. Puglisi, E.V., and, Puglisi, J.D. 2011. Secondary structure of the HIV reverse transcription initiation complex by NMR. Journal of Molecular Biology, 410: 863-874.
51. Ratner, L., Haseltine, W., Patarca, R., Livak, K.J., Starcich, B., Josephsc, S.F., Doran, E.R.,., and, Robert. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature, 313: 277-284.
52. Rein, A., Henderson, L.E., and, Levin, J.G. 1998. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends in Biochemical Science, 23: 297-301.
53. Romo, T.D., and, Grossfield, A. 2011. Block covariance overlap method and convergence in molecular dynamics simulation. Journal of Chemical Theory and Computation, 7: 2464-2472.
54. Ryckaert, J.P., Ciccotti, G., and, Berendsen, H.J.C. 1977. Numerical integration of the Cartesian equations of motion of a systems with constraints; molecular dynamics of n-alkanes. Journal of Computer Physics, 23: 327-341.
55. Temin, H.M., and, Mizutani, S. 1970. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature, 226: 1211-1213.
56. Tisne, C., Rigourd, M., Marquet, R., Ehresmann, C., and, Dardel, F. 2000. NMR and biochemical characterization of recombinant human tRNA3Lys expressed in Escherichia coli: identification of posttranscriptional nucleotide modifications required for efficient initiation of HIV-1 reverse transcription. RNA, 6: 1403-1412.
57. Tripathi, S., Chaubey, B., Barton, B.E., and, Pandey, V.N. 2007. Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome. Virol, 363: 91-103.
58. Wakefield, J.K., Kang, S., and, Morrow, C.D. 1996. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(his). Journal of Virology, 70: 966-975.
59. York, D.M., Darden, T.A., and, Pedersen, L.G. 1993. The effect of long-range electrostatic interactions in simulations of macromolecular crystals: a comparison of the Ewald and truncated list methods. Journal of Chemical Physics, 99: 8345-8348.
60. Zhang, Z.J., Kang, S.M., Li, Y., and, Morrow, C.D. 1998. Genetic analysis of the U5-PBS of a novel HIV-1 reveals multiple interactions between the tRNA and RNA genome required for initiation of reverse transcription. RNA, 4 (4): 394-406.